Chemical produced in pancreas prevented and reversed diabetes in mice

June 28, 2011

A chemical produced by the same cells that make insulin in the pancreas prevented and even reversed Type 1 diabetes in mice, researchers at St. Michael's Hospital have found.

Type 1 , formerly known as juvenile diabetes, is characterized by the immune system's destruction of the in the that make and secrete insulin. As a result, the body makes little or no insulin.

The only conventional treatment for is insulin injection, but insulin is not a cure as it does not prevent or reverse the loss of beta cells.

A team led by Dr. Qinghua Wang, in the division of endocrinology and metabolism, and Dr. Gerald Prud'homme, in the division of pathology, has studied the role of GABA, or , an amino acid produced by beta cells in the pancreas. The research was funded by the Canadian Institutes of Health Research, the Juvenile Diabetes Research Foundation and the Canadian Diabetes Association.

The researchers found that GABA injections not only prevented diabetes in mice, but even reversed the disease. Their findings were published in the journal .

The significance of GABA is that it corrects both known causes of Type 1 diabetes in mice: It works in the pancreas to regenerate insulin-producing beta cells and it acts on the immune system to stop the destruction of those cells. Those two actions are necessary to reverse the disease and prevent its recurrence. Until now, there has been no effective treatment that achieves both goals at the same time.

GABA has been known for decades to be a key neurotransmitter in the brain, a chemical that use to communicate with each other, but its role in the pancreas was unknown. The St. Michael's study is the first to identify and describe GABA's importance in regulating the survival and function of in mice.

GABA and related therapies will have to be tested in human clinical trials before they can be considered as a new treatment for Type 1 diabetes, said Dr. Wang.

"GABA is the first agent to act both by protecting the insulin-producing cells from damage and by decreasing the body's immune reaction against these cells," said Dr. Gary F. Lewis, incoming director of the Banting and Best Diabetes Centre and Director of the Division of Endocrinology and Metabolism at the University of Toronto, where insulin was discovered 90 years ago.

"The body's immune reaction against its own insulin-producing cells is responsible for most of the damage that leads to the development of type 1 diabetes. This exciting observation may open up new avenues for the prevention and treatment of Type 1 diabetes in humans."

Drs. Wang and Prud'homme are both clinician scientists in the Keenan Research Centre of the Li Ka Shing Knowledge Institute of St. Michael's Hospital. In addition, Dr. Wang is an associate professor in the Department of Physiology at the University of Toronto and Dr. Prud'homme is a professor in the university's Department of Laboratory Medicine and Pathobiology.

"Diabetes research such as this brings us closer to a cure," said Michael Cloutier, president and CEO at the Canadian Diabetes Association. "We are excited to be a part of this significant discovery and look forward to the outcomes of clinical studies."

Explore further: How insulin-producing cells develop -- new finding could help fight against diabetes

Related Stories

Compounds that trigger beta cell replication identified

February 25, 2009

Researchers at the Genomics Institute of the Novartis Research Foundation (GNF) have identified a set of compounds that can trigger the proliferation of insulin-producing cells in the pancreas, using sophisticated high-throughput ...

Gene therapy reverses type 1 diabetes in mice

June 21, 2010

Researchers have developed an experimental cure for Type 1 diabetes, a disease that affects about one in every 400 to 600 children and adolescents. They will present their results in a mouse model of Type 1 diabetes on Sunday ...

Recommended for you

Basic research fuels advanced discovery

August 26, 2016

Clinical trials and translational medicine have certainly given people hope and rapid pathways to cures for some of mankind's most troublesome diseases, but now is not the time to overlook the power of basic research, says ...

New method creates endless supply of kidney precursor cells

August 25, 2016

Salk Institute scientists have discovered the holy grail of endless youthfulness—at least when it comes to one type of human kidney precursor cell. Previous attempts to maintain cultures of the so-called nephron progenitor ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

Strict diet combats rare progeria aging disorders

August 25, 2016

Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want. These are findings of a joint study being published today ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.